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ABSTRACT 
 
  Cell membranes are integral for many biological processes. In addition to 
containing and protecting cellular contents and maintaining the chemical integrity of the 
cell, these interfaces host a variety of ligand-receptor interactions. These ligand-receptor 
interactions are important for cell signaling and transport and the ability to monitor them 
is key to understanding these processes. In addition, therapeutics and drug discovery is 
also aided by membrane-specific study, as  the majority of drugs target receptors 
associated with the cell surface.  
The cell membrane can be effectively mimicked by the use of supported lipid 
bilayers, which provide a robust platform exhibiting the lateral fluidity and composition 
associated with cell membranes. The ability to study both ligand-receptor interactions as 
well as small molecule-membrane interactions on these model membranes is aided by 
the fact that these assays can be multiplexed and are amenable to use with low sample 
volumes with high throughput. 
Our laboratory has recently developed a strategy for fluorescent microscopy 
studies of ligand-receptor interactions on supported lipid bilayers without the use of 
fluorescently-labeled analytes. This technique involves the incorporation of pH-sensitive 
fluorophores into the composition of the supported lipid bilayer as embedded reporter 
dyes. It was determined that this assay can operate as either a “turn-on” or a “turn-off” 
sensor depending on the analyte to be detected. It was additionally found that 
 iii 
modulating the ionic strength of the operating buffer allows for tuning the operating pH 
and sensitivity of the assay.  
This label-free technique can be utilized to monitor small peptide interactions 
with bilayers containing specific phospholipids. Basic amino acid sequences which are 
associated with transporting contents across membranes or anti-microbial activity can be 
monitored binding to negatively charged bilayers without the use of labels. Not only is 
this a sensitive technique for detecting small peptides, but thermodynamic data can be 
extracted as well. 
In a final set of experiments, the interaction of proteins with  phosphatidylserine 
(PS) in supported lipid bilayers is observed by utilizing PS-Cu
2+
-induced quenching of 
fluorophores. Disruption of this metal-phospholipid, specifically by Ca
2+
-dependent 
protein kinases, results in a turn-on fluorescent assay, which can be used to monitor the 
binding of the protein to PS and the effects of other metal interference.  
 
.  
 
 
 
 
 
 
 
 iv 
DEDICATION 
 
 This dissertation is dedicated to the people who have been so influential to me in 
the past five years. I would not have endeavored such an undertaking had it not been for 
my wonderful wife Andrea who was always supportive of my seemingly insane 
dedication to the task of research. I could not, nor would I have especially wanted to do 
this without her. I would also like to dedicate this to the friends that I have made in the 
course of this process, both within the Cremer group and within the Chemistry 
Department. Finally I would like to dedicate this to my daughter, whose imminent 
arrival has been an inspiration to finish this process 
 
 v 
ACKNOWLEDGEMENTS 
 
 I would like to thank my committee chair, Dr. Paul Cremer, for his guidance and 
encouragement. His enthusiasm and love of discovery greatly helped move me through 
some of the despairs inherent to this process. I would also like to thank my committee 
members, Dr. David H. Russell, Dr. Christian Hilty, and Dr. George R. Welch for 
challenging my ideas and understanding in seminars and defenses throughout the years, 
and helping me to become a better scientist. 
I would like to thank those who went before me, especially Dr. Hyunsook Jung 
and Dr. Chris Monson who taught me much about this research, Dr. Wei-Ssu Liao, Dr. 
Keith Chang, and Dr. Jaibir Kherb who both encouraged and befriended me as a new 
member of the lab. Dr. Michael Eller and Dr. Michael Grubb who entered the program 
along with myself and were good friends throughout its course. I would like to 
acknowledge the Cremer Group- one that has truly been a pleasure to work with and is 
populated with truly talented minds. I greatly appreciate all of the discussions, both 
scientific and otherwise, with Matt Poyton. He is a very good friend and a very good 
scientist. I’m glad that he chose to work in this lab and look forward to his future work. I 
would also like to thank Dr. Hudson Pace for his encouragement, commiseration, and 
genuine friendship over the past five years. He has been a worthy Minotaur opponent, a 
remarkable researcher, and most importantly a very good friend. A friend one is lucky to 
have made. Thanks to N.W. for keeping me attuned to that aspect of my life, and to Mr. 
Capestrano, Joe Pasteroni and the rest from Adobe Skyscraper. 
 vi 
TABLE OF CONTENTS 
 
              Page 
ABSTRACT ..............................................................................................................  ii 
DEDICATION ..........................................................................................................  i? 
ACKNOWLEDGEMENTS ......................................................................................  v 
TABLE OF CONTENTS ..........................................................................................  vi 
LIST OF FIGURES ...................................................................................................  viii 
LIST OF TABLES ....................................................................................................  x 
CHAPTER 
 I INTRODUCTION ................................................................................  1 
 
Objective .......................................................................................  1 
   Supported Lipid Bilayers ..............................................................  5 
   Microfluidics and Flow Cells ........................................................  7 
 
 II EXPERIMENTAL SECTION .............................................................  10 
   Materials .........................................................................................  10 
   Synthesis and Separation of Dye-Conjugated Phospholipids ........  11 
   Preparation of Small Unilamellar Vesicles ....................................  13 
                           Preparation of Glass Substrates ......................................................  13 
                           Fabrication of Microfluidic Devices ..............................................  15 
                           Fabrication of Flow Cells ...............................................................  16 
   Formation of Supported Lipid Bilayers .........................................  16 
                           Measurement of pH Titration Curves .............................................  17 
                           Fluorescence Microscopy Measurements ......................................  18 
                            
 
 
 
 vii 
CHAPTER                                                                                                                   Page                           
 
III TURN-ON AND TURN-OFF SENSING OF PROTEIN-LIGAND 
BINDING BY MODULATING BUFFER CONDITIONS .................       19  
 
  Introduction ....................................................................................       19 
  pH Titration Curves ........................................................................       23
  Sensing Avidin and Streptavidin ....................................................       23 
                  Altering Buffer Conditions to Optimize Assay ...............................       27 
                                Discussion .......................................................................................       36 
 IV LABEL-FREE MONITORING OF MEMBRANE-ASSOCIATED 
PEPTIDES ON SUPPORTED LIPID BILAYERS .............................       40 
  
     Introduction ......................................................................................       40 
       Flow-Cell and pH Titration Curves .................................................       45 
                              Nona Lysine Binding Experiments .................................................       48 
                                Nona Arginine Binding Experiments ..............................................       54 
     Discussion ........................................................................................       57 
                V LABEL-FREE MONITORING OF PROTEIN-PHOSPHATIDYL 
  SERINE INTERACTIONS ON SUPPORTED LIPID BILAYERS ...       61 
  
     Introduction ......................................................................................       61 
       C2α Binding Experiments ...............................................................       63 
                              Discussion .......................................................................................       71 
                      
         VI        CONCLUSIONS ..................................................................................       73 
 
 Discussion ......................................................................................       73 
      A Few Comments on Microfluidics ...............................................       74 
 
REFERENCES ..........................................................................................................       80 
 viii 
LIST OF FIGURES 
 
                                                                                                                                       Page 
 
Figure 1.1 Schematic of Ligand-Receptor Interaction on Cell Membrane ...........  2 
 
Figure 1.2 Schematic of Supported Lipid Bilayer .................................................  6 
 
Figure 1.3 Schematic of Fluorescence Microscopy Setup ....................................  9 
 
Figure 2.1  Mass Spec Confirmation of Dye-Conjugated Phospholipid ................  12 
 
Figure 2.2 Structures of Relevant Phospholipids ..................................................  14 
 
Figure 3.1 Schematic of pH Modulation Assay ....................................................  22 
Figure 3.2 Line Scans and pH Titration Curve for High Salt Buffer ....................  24 
Figure 3.3 Sensing of Streptavidin and Avidin Under High Ionic Strength .........  26 
Figure 3.4 Line Scan for para-Rhodamine B Control Assay ................................  28 
Figure 3.5 pH Titration Curves for High and Low Ionic Strength Buffers ...........  29 
Figure 3.6 Line Scans for pH Titration Curves in Figure 3.5 ................................  30 
Figure 3.7 Sensing of Streptavidin and Avidin Under Low Ionic Strength ..........  32 
Figure 3.8 Sensing of Streptavidin at Different pH’s ............................................  35 
Figure 3.9 Protein Sensing Signal at Different Buffer Concentrations .................  38 
Figure 3.10 pH Titration Curves for Different Buffers and Surface Chemistries ...  39 
Figure 4.1 Schematic for Peptide Sensing Assay ..................................................  44 
Figure 4.2 Fluorescence Micrograph and Line Scans for Bilayers in Flow Cell ..  46 
Figure 4.3 pH Titration Curves for Different mol% POPG Bilayers ....................  47 
Figure 4.4 Fluorescent Intensity vs. Time for Nona-Lysine Assay .......................  50 
 ix 
                                                                                                                                       Page 
 
Figure 4.5 Nona Lysine Binding Isotherms for 10, 20, and 30 mol% POPG .......  51 
Figure 4.6 Control Assay with POPC Bilayer .......................................................  53 
Figure 4.7 Nona Lysine Binding Isotherm for 5 mol% POPG ..............................  55 
Figure 4.8 Nona Arginine Binding Isotherms .......................................................  56 
Figure 5.1 Schematic of PS-Cu
2+
 Sensing Assay ..................................................  64 
Figure 5.2 Fluorescence Intensity Data for Cu
2+
 Quenching and De-quenching  .  66 
Figure 5.3 Line Scans for C2α Sensing Assay ......................................................  68 
Figure 5.4 Fluorescence Intensity Data for C2α Sensing Assay ...........................  69 
Figure 5.5 Binding Isotherm for C2α ....................................................................  70 
Figure 6.1 Fluorescence Intensity Data with Start and Stop Flow  .......................  76 
Figure 6.2 Fluorescence Intensity Data with Stopped Flow at Different pH’s .....  77 
Figure 6.3 Comparison of pH Titration in Microfluidic and Flow Cell ................  79 
 x 
LIST OF TABLES 
                                                                                                                                  Page 
Table 3.1 Summary of Protein Signal at Different Sensing Conditions ...................  33 
Table 4.1 Summary of Peptide Binding Data for Different PG Concentrations .......  48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
CHAPTER I 
INTRODUCTION  
 
Objective. Cell membranes are integral for many biological processes. In 
addition to containing and protecting cellular contents and maintaining the chemical 
integrity of the cell, these interfaces host a variety of ligand-receptor interactions. 
Because the majority of drugs target cell membrane-associated receptors
1
, being able to 
monitor ligand-receptor interactions on the cell membrane aids in therapeutic and drug 
discovery efforts.  The ability to monitor membrane interactions is also key to 
understanding such phenomena as polyvalent binding
2
 and association of proteins and 
small peptides with specific phospholipids
3,4
 (Figure 1.1). Traditionally, the use of 
fluorescent tags has been employed to monitor ligand receptor interactions on membrane 
surfaces.
5-7
 Indeed, our laboratory has made use of this technique to investigate the effect 
of hapten density
8
 and presentation
9
 on antibody binding. However, employing 
fluorescent labels can be costly and inefficient and may alter analyte behavior
10,11
 
especially in the case of small peptides.
12
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Figure 1.1. Schematic of Ligand-Receptor Interaction on Cell Membrane. Illustration 
shows (a) protein-ligand and (b) protein-phospholipid interactions on a cell membrane. 
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To avoid the possible interference of labels, spectroscopic techniques have been 
developed for monitoring interactions on surfaces such as surface plasmon resonance 
(SPR),
13-16
 surface enhanced Raman scattering
17
 and optical resonators.
18,19
 In addition,  
some non-spectroscopic techniques have been employed as well such as quartz-crystal 
 microbalance (QCM),
20-23
 semiconducting nanowires,
24-27
 and microcantilevers.
28-31
  
Although these techniques avoid the use of interfering labels, they can be costly or 
difficult to employ, may not be easily amenable to membrane studies, or may suffer 
from sensitivity compared to fluorescent techniques.
32
  
 Recently we have developed a technique for monitoring ligand-receptor 
interactions on membrane surfaces that utilizes the sensitivity of fluorescence 
microscopy without the use of labeling the analyte of interest.
33
 This technique allows 
for the label-free monitoring of membranes without the need for specially modified 
surfaces beyond annealed borosilicate glass cover slips.
34
 Essentially, this assay operates 
on the basis of effective pH modulation at a membrane surface upon the binding of an 
analyte such as a protein or antibody. The associated pH change, which is due to the 
charged nature of the analyte, can induce a fluorescent response from pH-sensitive 
fluorophores which have been incorporated into the composition of the membrane. We 
are interested in exploring this technique in terms of increasing signal response as well 
as expanding the effective pH range for operating the assay. This can be achieved 
through the modulation of the buffering species and ionic strength as well as through 
modulation of the surface charge via incorporation of charged phospholipid species. 
 4 
 The ability to monitor the binding of small basic peptides to bilayers is of interest 
for many reasons. Sequences of basic residues are ubiquitous with many membrane-
associated proteins,
35
 especially on regions of the proteins associated with the 
cytoplasmic side of the membrane where there is a greater distribution of negatively 
charged phospholipids.
36,37
 Additionally, cell-penetrating peptides (CPP’s), which can 
aid in the delivery of species across membranes
38-41
 contain basic amino acid sequences 
which are believed to facilitate delivery by first associating with negatively charged 
phospholipids in membranes. Basic residue sequences are also associated with anti-
microbial peptides,
42
 the understanding of which will greatly help in contending with 
multidrug antibiotic resistance. Techniques such as electrophoretic mobility, dye release 
assays, and even molecular dynamics have been utilized to study the manner in which 
these peptides associate and affect plasma membranes. We wish to utilized the 
previously described label-free technique as a simple and novel way to observe the 
interaction of short basic peptide sequences with bilayers in hopes of extracting kinetic 
and thermodynamic data. The utilization of microfluidics also helps in this regard, as 
low sample volumes can be used for these assays.  
 Phosphatidylserine (PS), a negatively charged phospholipid found in membranes 
that is involved in important communication events such as signaling the elimination of 
apoptotic cells, is also the major anionic eukaryotic phospholipid constituent.
43
 In 
addition to being a signaler for cell apoptosis, PS also functions as a highly specific 
binding target for coagulation proteins such as prothrombin in the clotting cascade.
44
 
Other PS-specific proteins include anticoagulant annexin V
45
 and conventional protein 
 5 
kinase C (PKC),
46,47
 both of which involve Ca
2+
-dependent coordination with PS. The 
ubiquitous nature of PS as a signaling lipid involved in such varied processes makes it an 
interesting candidate for bilayer studies, especially with regards to the Ca
2+
-dependent 
kinase. These phosphorylation enzymes contain a PS-specific binding motif referred to 
as the C2 domain which in addition to interacting with Ca
2+
 dependently with PS 
binding has shown competitive binding of contaminant metals such as Pb
2+
.
48
 
 We have recently determined that PS reversibly binds Cu
2+
 with extremely high 
affinity.
49
 This PS- Cu
2+
 complex exhibits quenching of fluorescent dyes incorporated 
into the same bilayer, a phenomenon that we seek to exploit as a sensor for PS-binding 
proteins. In this strategy, the disruption of the 2:1 PS: Cu
2+
 complex can lead to de-
quenching of phospholipid-conjugated fluorophores and act as a turn-on sensor. Not 
only does this allow for the label-free study of PS-binding motifs such as the C2 domain 
of PKC, but it also allows for information to be gained in regards to competition with 
Cu
2+
 for serine binding.  
 
Supported Lipid Bilayers. Supported lipid bilayers (SLB’s) are synthetic 
mimics of cell membranes and share the same phospholipid constituents thereof. Their 
composition can be tailored to incorporate specific ligands or phospholipid species, 
while maintaining the two-dimensional fluidity found in cell surfaces.
34
 These bilayers 
can form via spontaneous vesicle fusion
50,51
 and exist on a thin layer (10-20 Å) of water 
separating the lower leaflet and the solid support (Figure 1.2), allowing for unimpeded 
lateral lipid  
 6 
 
 
 
 
Figure 1.2. Schematic of Supported Lipid Bilayer. Diagram shows a supported lipid 
bilayer on a hydrophilic planar substrate. The substrate usually consists of quartz or 
fused silica and a thin layer of water between the substrate and the lower leaflet allows 
for two dimensional fluidity such as that found in cell membranes.  
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movement.
52
  Moreover, these membranes are amenable for use in multiplexed 
microfluidic devices.
53
 Phospholipids functionalized with biotin and pH-sensitive dye 
have been utilized to monitor the binding of avidin and streptavidin in different buffer 
conditions to further understand the nature of the label-free technique described earlier. 
In a similar fashion, SLB’s containing pH-sensitive dye and differing concentrations of 
phosphatidylglycerol (PG) were utilized to  study the binding of short basic peptide 
strands and the Cu
2+
-induced quenching of fluorophores in membranes was exploited 
with SLB’s containing PS to observe the Ca2+-dependent binding of C2 domains. 
 
Microfluidics and Flow Cells.  Microfluidic devices offer the ability to observe 
binding events on SLB’s while utilizing very small sample volumes53  and can be 
produced in a facile method using polydimethylsiloxane (PDMS) and glass.
54
 These 
devices also have the inherent advantage of multiplexing many bilayer studies 
simultaneously to both reduce the time constraint for performing assays under multiple 
conditions and reduce the temporal noise associated with illumination sources.  
 Traditionally our laboratory has made use of total internal reflection fluorescence 
microscopy (TIRFM) in conjunction with bilayer studies in microfluidics.
8,9,55
 However, 
since the studies performed herein are performed in a label-free manner, TIRFM can be 
replaced with traditional epifluorescence microscopy techniques, as illustrated in Figure 
1.3. After a PDMS mold is fabricated via soft lithographic techniques
56
 it is attached to 
an annealed glass cover slip after being rendered hydrophilic by treatment with oxygen 
plasma. Bilayers are formed inside the microfluidic channels via the vesicle fusion 
 8 
technique
53
 after which the desired buffer or protein solution is continually flowed 
though by gravity-driven flow. These bilayers can be monitored in real time with an 
inverted fluorescence microscope, allowing for facile determination of equilibration in 
binding experiments. This is advantageous, especially in regards to low concentrations 
where, as opposed to bulk solutions limited by diffusion, flow through microfluidics is 
laminar, resulting in a small no-slip region near the surface through which diffusion of 
analyte occurs rapidly.
57
 
 Another method for analyzing bilayers in real time under flowed conditions is the 
use of simple flow cells, made of circular PDMS wells ~ 1.5 µm  deep which contain µL 
of total volume. These wells can be patterned with fibrinogen and simple PDMS micro-
contact techniques.
58
 Although these flow cells lack the minute volume and ease of 
multiplexing that microfluidics offer, they are useful for avoiding complications with 
small PDMS channels.
59
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Figure 1.3. Schematic of Fluorescence Microscopy Setup. Illustration shows a typical 
microfluidic epifluorescence microscopy experimental setup. Solution is delivered to 
each microfluidic channel via gravity driven flow through polytetrafluoroethylene tubes. 
The microfluidic channels are monitored in real time with an inverted fluorescent 
microscope. 
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CHAPTER ?? 
EXPERIMENTAL SECTION 
 
Materials. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (POPG), 1,2-
dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DOPS), 1-hexadecanoyl-2-(9Z-
octadecenoyl)-sn-glycero-3-phosphoethanolamine) (POPE), and (1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) (biotin-cap PE) were all 
purchased from Avanti Polar Lipids (Alabaster, AL). Lissamine rhodamine B sulfonyl 
chloride and Oregon Green® 488 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine (Oregon Green® 488 DHPE) were both purchased from 
Invitrogen (Eugene, OR).  
 Streptavidin and avidin were both purchased from Rockland (Gilbertsville, PA) 
and bovine fibrinogen was purchased from  MP Biomedicals (Solon, OH). Phosphate 
buffers, sodium chloride, and MES buffer was purchased from Sigma-Aldrich (St. Louis, 
MO). Calcium chloride and copper(II) chloride were purchased from Acros (Pittsburgh, 
PA). Amidated nona-lysine (K9) was purchased from GenScript (Piscataway, NJ). 
Amidated nona-lysine and nona-arginine (R9) were provided by the Pellois Laboratory 
at Texas A&M University, and protein kinase C2-α was provided by the Igumenova 
Laboratory at Texas A&M University.  
 Purified water was obtained from a NANOpure Ultrapure Water System (18.2 
MΩ·cm, Barnstead). Glass cover slips used as supports for bilayers were purchased from 
 11 
Fischer Scientific (24 x 40 mm, No. 1.5) and polydimethylsiloxane (PDMS, Dow 
Corning Sylgard Silicone Elastomer-184), used for microfluidics and flow cells, was 
obtained from Krayden, Inc (El Paso, TX). Hydrofluoric acid and thin layer 
chromatography (TLC) plates (silica gel 60 F254) were purchased from EMD 
(Philadelphia, PA) and ammonium fluoride was purchased from Alfa Aesar (Ward Hill, 
MA). Polytetrafluoroethylene (PTFE) tubing (inner diameter 0.66 mm) was purchased 
from SPC Technology (Chicago, IL).  
 
Synthesis and Separation of Dye-Conjugated Phospholipids. To synthesize 
rhodamine B-POPE phospholipids, a primary amine reaction was utilized by mixing a 
solution of 10 mg of rhodamine B sulfonyl chloride in 1 mL of chloroform with 10 mg 
of POPE and 2 μL of diethylamine. The reaction was stirred for one hour at room 
temperature. After the reaction, the solution was spotted onto a TLC plate (EMD, 5715-
7, silica gel 60 F254) and developed with a chloroform:methanol mixture (92:8) to 
obtain rhodamide-B labeled POPE. The mixed isomers of rhodamine B-POPE could be 
further separated on another TLC plate developed with ammonium hydroxide solution: 
n-propanol (35: 65). The reaction was confirmed with matrix-assisted laser desorption 
ionization mass spectrometry (Figure 2.1).  
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Figure 2.1. Mass Spec Confirmation of Dye-Conjugated Phospholipid. Matrix assisted 
laser desorption ionization mass spectrum showing a peak at 1258.6 (rhodamine-B 
POPE + 2H+). 
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Preparation of Small Unilamellar Vesicles. To make small unilamellar 
vesicles, first a mixture of the desired phospholipids were mixed in chloroform before 
being dried by purging with nitrogen gas. The mixtures were then desiccated under 
vacuum for three hours before being reconstituted in 10 mM phosphate buffer with 150 
mM NaCl to a concentration of 0.5 mg/mL. After the lipids were fully dissolved in the 
buffer solution, they were subjugated to ten freeze-thaw cycles by immersion in liquid 
nitrogen and warm water. This was followed by at least seven extrusions using a Lipex 
extruder (Northern Lipids Inc., Vancouver, Canada) through two stacked polycarbonate 
filters (Whatman) with 100 nm hole diameters. Size of the extruded vesicles was 
determined by dynamic light scattering (Brookhaven Instruments 90Plus Particle Size 
Analyzer) with typical sizes between 90 and 100 nm. Vesicle solutions were stored at 4 
ºC until use. Structures of the phospholipids utilized in these studies are shown in Figure 
2.2. 
 
Preparation of Glass Substrates. Glass substrates for accommodating lipid 
bilayers were prepared from Fischer glass cover slips (24 x 40 mm, No. 1.5) by first 
boiling in a 1:6 solution of 7X cleaning solution (MP) and water for at least one hour. 
This was followed by rinsing with copious amounts of purified water before drying 
thoroughly with nitrogen gas. The cover slips were then annealed for five hours at 520 
ºC before being stored until use.  
 14 
 
Figure 2.2. Structures of Relevant Phospholipids. Structures of a) POPC, b) POPG, c) 
POPE, d) DOPS, e) DOPE-biotin cap, f) ortho-rhodamine B, and g) para-rhodamine B. 
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Fabrication of Microfluidic Devices. Seven channel microfluidic devices with 
channel widths of ~120 µm and heights of ~50 µm were produced via soft lithographic 
techniques.
53
 Glass slides (soda lime, Corning) were first cleaned by immersion for one 
hour in a 25:75 (v/v) mixture of concentrated hydrogen peroxide and concentrated 
sulfuric acid. The slides were then rinsed with copious amounts of water and dried under 
a stream of nitrogen. A layer of photoresist (Shipley 1827) was then spin-coated on the 
surface of the slides which were then exposed to UV for 12 seconds at > 400 W through 
an appropriate negative mask. The slides were treated with developing solution and any 
stray photoresist was removed with acetone before baking at 120 ºC overnight. Buffered 
oxide etchant (BOE) was used to etch the patterns into the glass slides. The glass was 
immersed in a BOE solution prepared from a 1:6 ratio (v/v) of 48% hydrofluoric acid 
(EMD Chemicals Inc., Germany) and aqueous ammonium fluoride (200 g in 300 mL 
purified water, Alfa Aesar, Ward Hill, MA) then immersed in 1 M HCl followed by 
rinsing with water. This process was repeated up to six times before the remaining 
photoresist was removed with acetone. The surface was rendered hydrophobic by vapor 
deposition of tricholododecylsilane. A 10:1 (v/v) mixture of Sylgard silicone elastomer-
184 and a curing agent were degassed under vacuum before being poured over the glass 
pattern. This polymer was then cured for one hour at 70 ºC before being peeled off of the 
glass surface. The polymer and a glass cover slip which had been prepared as described 
previously were then treated with 25 W oxygen plasma for 30 seconds before being 
brought into contact, forming the PDMS microfluidic device. 
 
 16 
Fabrication of Flow Cells. A sheet of PDMS 1.5 µm thick was produced by 
curing the polymer between two hydrophobized glass slides separated by cover slips 1.5 
µm in thickness. A hole was cut into the center of the PDMS sheet and the well was 
placed on a clean coverslip. A PDMS stamp which was cured over a seven channel 
microfluidic pattern was incubated in a 1 mg/mL bovine fibrinogen solution, then 
pressed onto the glass cover slip in the well and allowed to set for five minutes before 
being removed. Vesicles were then deposited in the well and incubated for ten minutes 
before being rinsed with copious amounts of water. A second sheet of PDMS with an 
inlet and an outlet hole was then placed on top of the well, and the entire structure was 
held together by aluminum plates with two clips. Solution was flowed through the 
device as experiments were performed. 
 
Formation of Supported Lipid Bilayers. Vesicle solutions were diluted 1:1 
with 1 M NaCl before being introduced to microfluidic channels. These were allowed to 
incubate for at least ten minutes before being rinsed with buffer to remove excess 
vesicles. The fluorescence of each bilayer was able to be monitored as buffer was flowed 
over it to ensure that equilibration had been achieved before any experimental additions 
were made. Precautions were taken to avoid the introduction of any air bubbles into the 
channels. Likewise, flow rates were kept so that bilayers were not damaged, usually 
achieving rates of ~50 µL/hr. 
 
 17 
Measurement of pH Titration Curves.  Titration curves for various bilayer and 
buffer conditions were performed within microfluidic devices or flow cells. After 
bilayers had been deposited, buffer of specific pH which had been previously prepared 
and measured with a pH meter (Orion 3-Star, Thermo Scientific) was flowed into the 
microfluidic or flow cell. The phosphate buffers with (or without) NaCl were produced 
by combining appropriate amounts of NaH2PO4, Na2HPO4, and Na3PO4.  Fluorescence 
was allowed to stabilize before a new pH buffer was flowed and fluorescent micrographs 
were captured with a Nikon Eclipse Ti-U fluorescence microscope (Tokyo, Japan) 
equipped with a ProEM 1024 CCD camera (Princeton Instruments) and a 4x air 
objective (N.A.=0.13). The fluorescence measurements were normalized to the 
maximum value and the data set was fit with a four parameter logistic curve: 
                                        
 
 
where y is the fluorescence intensity, x is the pH, K is the inflection point which 
corresponds to the apparent pKa and H is the Hill slope. 
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Fluorescence Microscopy Measurements.  Fluorescence measurements were 
made with an inverted Nikon Eclipse Ti-U fluorescence microscope (Tokyo, Japan) 
equipped with a ProEM 1024 CCD camera (Princeton Instruments) and a 10x air (N.A.= 
0.45) objective. A Texas Red filter set (Chroma Technology, Bellows Falls, VT) was 
used with a Lumen 200 (Prior Scientific) light source. All fluorescent images were 
processed with MetaMorph software (Version 7.7.0.0, Universal Imaging). 
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CHAPTER III 
TURN-ON AND TURN-OFF SENSING OF PROTEIN-LIGAND BINDING BY 
MODULATING BUFFER CONDITIONS 
 
Introduction. The ability to monitor ligand-receptor interactions is a necessity 
for biotechnological advances as well as a fundamental understanding of cell biology. 
The single-molecule sensitivity that fluorescent labeling can provide and the relative 
ease of fluorescence measurements has resulted in the utilization of this technique for 
detecting and monitoring proteins and nucleotides. Fluorescent labels can, however, 
interfere with analyte activity and can be difficult to efficiently employ.
10,11
 Many 
sensing techniques have consequently been developed such as quartz-crystal 
microbalance (QCM),
20-23
 surface plasmon resonance (SPR),
13-16
 semiconductor 
nanowire conductivity,
24,25
 and optical microcavities that avoid the use of fluorescent 
labels.
18
 Although these techniques avoid the problems associated with directly attaching 
fluorescent tags to analytes, they can behave non-linearly in response to analyte 
concentration, require specialized equipment or procedures which can be difficult and/or 
costly to employ, or possess poorer detection limits than fluorescence techniques.  
It is advantageous to be able to monitor ligand-receptor interactions on supported 
lipid bilayers
60
 because these platforms effectively act as a simplified cellular surface, 
incorporating the same lipid molecules as well as maintaining two-dimensional lipid 
fluidity.
34
 Indeed, the majority of current drug target ligands are associated with the cell 
surface,
1
 making the ability to effectively monitor such systems key for therapeutics and 
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drug discovery. Consequently, much work has been done to produce supported lipid 
bilayers that mimic the cellular surface with various supports
61-64
 or tethers.
65-70
 With the 
incorporation of microfluidic devices,
53
 such supported lipid bilayer systems can be 
produced in a rapid and facile method while utilizing only small amounts of analyte. 
Heterogeneous flow-based microfluidic techniques also afford the ability to change 
parameters such as ionic strength or buffer pH and monitor fluorescent response in real 
time. The ability to utilize glass substrates as membrane supports is also advantageous as 
these surfaces can readily accommodate fluid lipid bilayers
50,51
 via simple and rapid 
vesicle fusion.  
Recently, we have developed a sensing technique that utilizes the sensitivity of 
fluorescent measurements while avoiding the complications of directly labeling the 
analyte of interest.
33
 This technique involves the incorporation of a pH sensitive dye, 
ortho-conjugated Texas Red DHPE (Texas Red 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt), into a supported lipid bilayer containing 
the ligand biotin-PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap 
biotinyl) (sodium salt)). This isomer of Texas Red loses fluorescence when it is 
deprotonated at higher pH, while the para-conjugated isomer retains its fluorescence and 
therefore serves as a reference dye.
71
 Upon the binding of a negatively charged protein, 
the effective pH near the binding event will be lowered due to the protein’s recruitment 
of hydronium ions, thus causing protonation and increased fluorescence in the ortho-
Texas Red isomer. This “turn on” sensing approach was demonstrated using the 
biotin/anti-biotin binding pair.
33
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Herein, we have utilized the ortho isomer of rhodamine B (Lissamine rhodamine 
B sulfonyl chloride, mixed isomers) conjugated to the free amine of POPE (1-
hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine) as the reporter 
dye incorporated into the bilayer. Rhodamine B is far less expensive and the ortho 
isomer exhibits a more complete quenching behavior at high pH compared to ortho-
Texas Red. Additionally, the ortho isomer of rhodamine B exhibits pH-sensitive 
fluorescence at more acidic pH values compared to ortho-Texas Red.
72
 This allows for 
the detection of positively charged proteins near neutral pH. The sensor works in a 
manner similar to the detection of negatively charged species, except that a decrease in 
fluorescence accompanies a binding event because the surface becomes more positively 
charged and the effective local pH is therefore increased (Figure 3.1). The use of 
avidin/biotin and streptavidin/biotin binding pairs were implemented to test these ideas 
in both “turn off” and “turn on” mode (Figure 3.1). Avidin has an isoelectric point (pI) 
of ~10.
73
  It is therefore positively charged at a working pH of 7.2 and, in fact, caused a 
decrease in fluorescence upon membrane binding. For streptavidin, there was an increase 
in fluorescence upon binding as expected at pH ranges near or above the protein’s 
reported isoelectric point 6.4,
73
 while a decrease in fluorescence accompanied binding at 
pH values below the pI. Moreover, by modulating the ionic strength of the buffer used in 
this assay, it was possible to both increase the sensitivity of the detection response as  
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Figure 3.1. Schematic of pH Modulation Assay. Illustration shows the pH modulation 
assay in both “turn-off” and “turn-on” mode. (a) A positively charged protein (e.g., 
avidin) recruits hydroxide ions upon binding and renders the membrane surface more 
basic, decreasing the fluorescence of the dye. (b) A negatively charged protein (e.g., 
streptavidin) recruits hydronium ions, and upon binding enhances the fluorescence of the 
dye molecules nearby by rendering the surface more acidic 
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well as shift the apparent pKa of the ortho-rhodamine B dye, offering different pH 
ranges for detection assays. 
 
pH titration curves. Initial experiments were performed to obtain titration 
curves for 0.5 mol% ortho-rhodamine B-POPE in POPC bilayers with 0 and 5 mol% 
biotin PE. The pH of the bulk solution above the bilayers was altered via the continuous 
flow of a specific PBS solution with 150 mM NaCl and fluorescent images were 
captured until stabilization occurred. Once the fluorescent intensity stabilized for a given 
pH, the fluorescent intensity value was recorded and a different pH was flowed over the 
bilayer as the process was repeated (Figure 3.2). Representative intensity line scans for 
these measurements can be found in Figure 3.2 a. The bilayer fluorescence data was 
normalized to the pH value with the maximum fluorescence intensity. The intensity 
measurements versus pH value curves for the two bilayer conditions were fit to a 
sigmoidal curve (solid lines in Figure 3.2 b) and the apparent pKa values were extracted. 
Values of 6.2 ± 0.1, and 6.5 ± 0.1 were obtained for bilayers with 0 mol% and 5 mol% 
biotin-PE, respectively.  
 
Sensing Avidin and Streptavidin. Next, experiments were performed with 
POPC bilayers containing 5 mol% biotin PE and 0.5 mol% ortho-rhodamine B POPE in 
both “turn on” and “turn off” mode. For these experiments, avidin and streptavidin were 
utilized as the binding analytes of interest as they both share a strong affinity for biotin.
74
 
Specifically, experiments were performed at pH 7.2, which falls within the linear  
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Figure 3.2. Line Scans and pH Titration Curve for High Salt Buffer. pH titration: (a) 
Fluorescence intensity line scans across channels containing bilayers composed of 0.5 
mol% ortho-rhodamine B POPE (oRB) and POPC with and without 5 mol% biotin. (b) 
Titration curves for each membrane composition. Y axis values were obtained from the 
intensity of the fluorescence line scan at each pH divided by the maximum fluorescence 
intensity for the titration. The solid circles represent individual fluorescence 
measurements and the solid lines are sigmoidal fits to the data. 
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response range of the dye as a function of pH (Figure 3.2). Under these conditions, 
streptavidin carries a net negative charge while avidin carries a net positive charge.
73
 To 
perform an experiment, three parallel microfluidic channels were coated with POPC 
bilayers containing ortho-rhodamine B-POPE and biotin PE, a third control channel was 
coated with POPC bilayers containing ortho-rhodamine B-POPE, but no biotin PE 
(Figure 3.3 a). Fluorescent micrographs were captured every five minutes as 10 mM 
PBS buffer at pH 7.2 with 150 mM NaCl was flowed through each channel until 
stabilization occurred. 300 nM of streptavidin was then flowed into left channel, while 
300 nM of avidin was flowed into the middle channel and the right channel. Data were 
collected every five minutes. The fluorescence intensity from each channel as a function 
of time is shown in Figure 3.3 b. Moreover, the individual fluorescence line scans at 0 
and 65 minutes are shown in Figures 3.3 c-e. Following a 30 minute stabilization period, 
300 nM protein in the same buffer was introduced to each channel. With the introduction 
of streptavidin, the fluorescence was increased by about 5% whereas the addition of 
avidin resulted in a decrease in fluorescence intensity of about 20%. The control channel 
showed no change in signal upon the addition of avidin. The difference in signal elicited 
from each protein reflects the isoelectric point of the protein and the operating pH of the 
experiment. Indeed, the experiment is conducted just above the isoelectric point for 
streptavidin, but lies far below the isoelectric point of avidin. Consequently, avidin is 
expected to be a more highly charged species at this pH
75
 and therefore perturb the 
apparent local pH above the supported lipid bilayer to a much greater extent upon 
binding. 
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Figure 3.3. Sensing of Streptavidin and Avidin Under High Ionic Strength. Protein 
sensing: (a) Fluorescence image of a bilayer-coated microfluidic channel containing 0.5 
mol% ortho-rhodamine B, 5 mol% biotin PE and POPC and a control bilayer lacking 
biotin PE. The red dashed line corresponds to the region in which fluorescent intensity 
measurements were made before and after introduction of protein. (b) Average channel 
intensity as a function of time before and after the introduction of streptavidin (blue), 
avidin (red) or avidin without biotin in the bilayer (green).  Experimental line profiles of 
the microfluidic channels before and after the addition of (c) 300 nM streptavidin, (d) 
300 nM avidin and (e) 300 nM avidin to a control bilayer. A 10× air objective was used 
to make all measurements and experiments were run in 10 mM PBS buffer with 150 mM 
NaCl at a bulk pH of 7.2. 
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To ensure that the “turn-off” sensor for avidin was indeed due to the binding of 
the protein and consequential increase the local hydronium ion concentration rather than 
photobleaching of the dye, control experiments were carried out on biotinylated 
membranes utilizing the pH-insensitive para isomer of rhodamine B-labeled POPE with 
5 mol% biotin-PE. As expected, the fluorescence intensity did not change in this assay 
(Figure 3.4). 
 
Altering Buffer Conditions to Optimize Assay. To probe the effect of salt 
screening on fluorescence response, experiments were carried out using 10 mM PBS 
without NaCl. This resulted in a buffer with decreased ionic strength and consequentially 
an increased Debye length.
76
 This should enhance the sensitivity of the assay by 
effectively increasing the area of the bilayer that will be influenced by the binding of a 
protein. Specifically, under high salt conditions (150 mM NaCl) in a 10 mM PBS buffer, 
the Debye length is about 6.6 Å.
76
 When a 10 mM PBS buffer is used without NaCl, the 
Debye length increases to about 12.4 Å, providing each protein a greater range of 
influence on reporter dyes in the proximity. A titration curve performed under these 
conditions on bilayers consisting of 0.5 mol% ortho-rhodamine B, 5 mol% biotin-PE in 
a POPC matrix resulted in a shift in the apparent pKa of ortho-rhodamine B dye by 
about 1 pH unit, as can be seen in Figure 3.5. The line scans from which these titration 
curves were created can be seen in Figure 3.6. This shift is not surprising, considering 
that decreasing the ionic strength of a solution should lead to an increase in the apparent 
pKa of a titratable species as predicted by Debye-Hückel theory.
77
 This condition  
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Figure 3.4. Scan for para-Rhodamine B Control Assay. Fluorescence intensity line 
profile data corresponding to a bilayer composed of 5 mol% biotin and 0.5 mol% para-
rhodamine B-POPE in POPC before and after the addition of 300 nM avidin. 10 mM 
PBS with 150 mM NaCl at pH 7.2 was used 
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Figure 3.5. pH Titration Curves for High and Low Ionic Strength Buffers. Titration 
curves for two buffer conditions with supported POPC bilayers containing 0.5 mol% 
ortho-rhodamine B and 5 mol% biotin-PE. The Y-axis values were obtained from the 
intensity of the fluorescence at each pH divided by the maximum fluorescence intensity 
for the titration. The solid circles represent individual fluorescence measurements, and 
the solid line is a sigmoidal fit to the data. 
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Figure 3.6. Line Scans for pH Titration Curves in Figure 3.5. Fluorescence intensity line 
profile data from which titration curves were extracted in Figure 3.5. 
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consequentially shifts the linearly-responsive pH range so that experiments can be run at 
a pH of 8.1, where streptavidin is more negatively charged, but avidin is somewhat less 
positively charged. 
To test low ionic strength conditions on sensor response, bilayers were formed 
inside two parallel microfluidic channels with and without 5 mol% biotin-PE. The 
bilayers were rinsed with 10 mM PBS until the fluorescence stabilized. Next, 300 nM 
streptavidin was introduced to the bilayers in a pH 8.1 buffer composed of 10 mM PBS 
and 150 mM NaCl and flowed for 30 minutes until the fluorescence response stabilized. 
Following the incubation, the channels were flushed with 10 mM PBS buffer until the 
signal stabilized again. Identical experiments were also performed with avidin. As can 
be seen in Figure 3.7, the introduction of streptavidin resulted in an increase in 
fluorescence whereas the introduction of avidin resulted in a fluorescence decrease. 
Because this assay was run at a lower ionic strength, there is concern that non-specific 
adsorption may occur due to electrostatic interaction between the protein and the bilayer, 
leading to signal from biofouling. However, the control channel in each channel pair, 
which lacked biotin, demonstrated that any non-specific adsorption was very low under 
these conditions. 
The relative change in signal under each set of conditions is provided in Table 
3.1. As can be seen, this was a factor of three for streptavidin from high ionic strength 
conditions to low ionic strength conditions. The change was even larger for avidin, a 
factor of six. This is quite curious as streptavidin should contain a higher negative charge 
at pH 8.1 compared with 7.2 as it is further from its isoelectric point. Therefore, signal  
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Figure 3.7. Sensing of Streptavidin and Avidin Under Low Ionic Strength. Protein 
sensing in 10 mM PBS: Line scans for microfluidic channels before and after the 
addition of streptavidin or avidin. (a) Bilayer composed of 0.5 mol% ortho-rhodamine B 
and 5 mol% biotin-PE in POPC before and after the addition of streptavidin. (b) Control 
bilayer composed of 0.5 mol% ortho-rhodamine B in POPC before and after addition of 
streptavidin. (c)  Bilayer composed of 0.5 mol% ortho-rhodamine B and 5 mol% biotin-
PE in POPC before and after the addition of avidin, and (d) control bilayer composed of 
0.5 mol% ortho-rhodamine B in POPC before and after addition of avidin. 
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Table 3.1. Summary of Protein Signal at Different Sensing Conditions.  
Protein Experimental Conditions Average Ending 
Signal with Respect 
to a Starting Signal of 
1.0 
Streptavidin 10 mM PBS 150 mM NaCl, 
pH 7.2 
+1.07 
10 mM PBS, pH 8.1 +1.21 
10 mM PBS 150 mM NaCl, 
pH 5.9 
-0.95 
Avidin 10 mM PBS 150 mM NaCl, 
pH 7.2 
-0.88 
10 mM PBS, pH 8.1 -0.26 
 
should increase on both protein charge as well as ionic strength grounds. By contrast, 
avidin should be closer to its isoelectric point at pH 8.1 than at 7.2. Therefore, a higher 
response is only expected because of the reduced screening, while the lower protein 
charge should actually lead to reduced signal. 
To separate the effects of ionic strength and pH, a final set of experiments was 
designed, in which the fluorescence response was monitored as a function of pH at 
constant ionic strength for streptavidin. Because the isoelectric point for this protein is 
near neutral pH, it is expected that the assay should change from turn-on to turn-off 
 34 
mode if the assay is run at sufficiently acidic pH. To test this idea, supported POPC 
bilayers were form with 0.5 mol% ortho-rhodamine B and 5 mol% biotin-PE in two 
parallel microfluidic channels. In each case, the solution contained 10 mM PBS with 150 
mM NaCl, but the experiments were run at pH 5.9 and 7.4. Data in Figure 3.8 displays 
the results. For the first 30 minutes, pure buffer at each respective pH was flowed over 
the system in the absence of protein. This provided a fluorescence intensity benchmark 
with which to compare protein-bound conditions. Following stabilization, 300 nM 
streptavidin diluted into the respective rinsing buffer was flown into each channel. As 
can be seen, pH 7.3 showed an intensity increase compared with the absence of protein, 
but pH 5.9 showed a decrease, which is consistent with the macromolecule being below 
its isoelectric point. Thus, turn off behavior is observed under these more acidic 
conditions (Table 3.1). 
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Figure 3.8. Sensing of Streptavidin at Different pH’s. Fluorescence intensity 
measurements before and after the addition of streptavidin at different pH 10 mM PBS 
150 mM NaCl buffers. Each point represents the average intensity of a microfluidic 
channel at a given time. 
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Discussion.  Two constraints apply to the sensor that has been described. Firstly, 
it is necessary that this system operate at pH ranges in which there is a linear response to 
fluorescence intensity with changing pH. It is also necessary that proteins of interest be 
sufficiently charged to induce a detectable change in fluorescence upon binding. 
Through the manipulation of the ionic strength of the operating buffer, it was possible to 
shift the linear range of the system to higher pH levels and thus increase the operating 
range of the system, consequently allowing for detection of proteins at pH’s adequately 
far from their pI’s. As can be seen from Figure 3.5, a system comprised of POPC, biotin 
PE, and rhodamine B-POPE operates linearly in a pH range from 5.9 to 7.3. By 
removing the 150 mM NaCl from the 10 mM PBS operating buffer, this linear range was 
shifted upwards to pH 8.1, resulting in a shift in apparent pKa for the rhodamine B-
POPE of ~1. This results in an average signal upon binding that is three times higher for 
streptavidin and more than five times higher for avidin. It should be noted that though 
the bulk pH is well controlled, the  hydronium activity near the bilayer surface is 
affected not only by the buffer, but by the chemistry of the membrane and the solid 
support as well which results in the measurement of apparent pKa shifts only. While the 
reduction of ionic strength allows for a shift in the apparent pKa of the dye and 
consequential operation at higher pH ranges, it also must affect the signal by increasing 
the area on the bilayer that each protein affects upon binding.  
In the case of avidin, operating the assay under a lower ionic strength  but at a 
higher pH, 8.1 instead of 7.3, results in an operating pH that is closer to the protein’s 
isoelectric point. However, the results show that this is a more sensitive assay for this 
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protein, indicating that at pH ranges sufficiently below (or above) a protein’s isoelectric 
point, the charged state of the protein is positive (or negative) enough to elicit 
fluorescent response from the dye. The lysines and asparagines in avidin should render 
this protein sufficiently basic at both pH 7.3 and 8.1, so that it is the effect of decreased 
ionic strength that enables one condition to be more sensitive that the other.  It is 
therefore important to consider both the operating pH and consequential charge of the 
protein as well as the Debye length and consequential “footprint” of the binding protein 
when optimizing this assay for increased overall signal. In the case of streptavidin, when 
assays were performed with increasing ionic strength but at a constant pH the sensitivity 
decreased (Figure 3.9) further supporting this idea.  
This label-free assay can be utilized to detect the interactions of charged species 
with a supported lipid bilayer in pH ranges that can be tuned not only through the 
modulation of the ionic strength of the buffer but through modulation of the buffering 
species as well as the composition of the bilayer itself. Representative titration curves 
are shown in Figure 3.10 which detail ortho-rhodamine B-POPE fluorescence response 
to pH in different buffering conditions and with different bilayer chemistries. Strategic 
selection of the appropriate combinations of buffer, ionic strength, and surface chemistry 
affords the ability to tune this assay to conditions that favor the identification of specific 
membrane-interacting species. 
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Figure 3.9. Protein Sensing Signal at Different Buffer Concentrations. Fluorescence 
response relative to a starting signal of 1 after addition of 300 nM streptavidin at pH 8.1 
in buffers of varying ionic strength. Bilayers consisted of 0.5 mol% ortho-rhodamine B-
POPE and 5 mol% biotin in POPC. Error bars correspond to standard deviation of 
multiple fluorescent measurements made on each channel after stabilization. 
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Figure 3.10. pH Titration Curves for Different Buffers and Surface Chemistries. 
 
 
 
 
 
 
 
 
 
 
 
 40 
CHAPTER IV 
LABEL-FREE MONITORING OF MEMBRANE-ASSOCIATED PEPTIDES ON 
SUPPORTED LIPID BILAYERS 
 
Introduction. The ability to study the interaction between negatively charged 
phospholipids and basic peptide sequences is appealing for several reasons. Firstly, there 
exist many proteins which contain amino acid sequences rich in basic residues in their 
membrane associating regions which facilitate interaction with negatively charged 
phospholipids such as phosphatidylserine (PS) or phosphatidylglycerol (PG) within 
plasma membranes. Often these residues are located within the cytoplasmic region of 
membrane-associated proteins, thereby aiding in the orientation of the protein within the 
membrane.
78,79
 For example, the membrane-spanning glycophorin A, one major human 
erythrocytic  sialoglycoprotein, contains a high percentage of basic residues in its 
intramembranous region.
80
 Membrane-associated proteins also exhibit basic amino acid 
motifs, a striking example being  the myristoylated alanine-rich C kinase substrate 
(MARCKS)  enzyme, the beginning sequence of which is comprised of five consecutive 
lysine residues.
81,82
 Protein kinase C is also believed to utilize basic amino acid lengths 
in its PS association and subsequent activation.
83
 Similarly, many acidic phospholipid-
associated cytoplasmic proteins are believed to bind via basic amino acid sequence 
motifs.
84,85
 
Basic amino acid residues are also associated with all classes of antimicrobial 
peptides.
42
 These peptide sequences utilize the electrostatic interaction of positively 
 41 
charged amino acids with negatively charged bacterial membranes and as such are key in 
the discriminate defense of zwitterionic eukaryotic cells against invading pathogenic 
species.
86,87
 There is great diversity in describing the mode of operation for antimicrobial 
peptides, such as barrel stave
88
 and toroidal
89
 pore formation as means of disrupting 
microbial membranes, though pore formation is not evident as the means by which most 
antimicrobial peptides operate.
90
 Instead, it appears that the majority of antimicrobial 
peptides disrupt bacterial membranes via more non-specific interactions. The aptly 
named carpet model in which peptide accumulation parallel to the membrane can 
eventually result in a critical concentration and subsequent internalization, resulting in 
the overall disruption of the bilayer was originally used to describe the membrane 
permeating behavior of positively charged mammalian cecropins.
91
 A more general 
description of the membrane destabilizing activity of antimicrobial peptides involves the 
intercalation of peptides into the lipid membrane in a similar manner as detergent 
molecules infiltrating and ultimately disintegrating bilayers.
92
 Regardless of the inherent 
mechanism associated with antimicrobial activity, the presence of positive amino acid 
residues remains a constant characteristic of these peptides. With increasing incidence of 
microbial resistance to drug therapies
93
 there exists a pressing need to explore the 
utilization of antimicrobial peptides as possible therapeutic solutions.  The ability to 
study simplified model peptides may give insight into the nature of antimicrobial 
membrane association. 
Finally, basic residues play a major role in the membrane translocating properties 
of cell-penetrating peptides (CPP’s). One of the main challenges for delivering 
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therapeutic drugs, specifically those targeted for intracellular organelles such as the 
mitochondria or nucleus, is transport of these agents across cell membranes.
94
 It was 
originally discovered that tumor cells experienced uptake of albumin facilitated by basic 
amino acids and histones, especially those containing arginine
95
 and after the HIV 
transactivator of transcription (Tat) protein was shown to be able to permeate cell 
membranes,
96,97
 identification of the active residue sequence which enabled this 
membrane permeability was accomplished.
98
 This multi-arginine and lysine containing 
sequence, in addition to many other cell penetrating peptides sequences,  has been used 
in the transport of cargos and therapeutics into cells.
99-102
 For the majority of CPP’s, 
activity is related to the peptides being composed of multiple arginine and/or lysine 
residues, and therefore holding a positive charge at physiological pH. Through 
electrostatic interactions, in addition to potential hydrogen bonding in the case of 
arginine-containing peptides,  association with membrane surfaces can lead to 
internalization of peptides and their cargo.
94
 Therefore, the ability to study the 
interaction of arginine and lysine-containing peptides  with plasma membranes can be 
useful for insight into this association process and may bring about strategies for 
delivery of therapeutic cargos into cells. 
 Indeed, studies involving techniques such as ultrafiltration, dialysis, and 
electrophoretic mobility measurements have been performed studying the interaction of 
various lengths of peptides composed of lysine and arginine with negatively charged 
vesicles.
4,103-105
 This, in association with computational modeling,
12
  has shed light on 
the nature of simple cationic peptide association with negatively charged phospholipids. 
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Because fluorescent labels on these peptide sequences can drastically alter their 
association properties,
12
 it is desirable to monitor their interactions in a label-free 
manner.  
The development of label-free monitoring on supported lipid bilayers via local 
pH-modulation affords the opportunity to study the interaction of small basic peptides 
with negative phospholipid membranes in real-time continuous flow. A pH-sensitive dye 
such as ortho-rhodamine B conjugated to a phospholipid is present in a supported lipid 
bilayer that contains some percentage of PG. When a positively charged peptide such as 
nona-lysine is introduced and binds to the membrane surface, this will result in 
modulation the local hydroxide activity. In this case, as ortho-rhodamine B loses its 
fluorescence when deprotonated at higher pH, a decrease in fluorescence of the bilayer 
will accompany a peptide binding event (Figure 4.1). Thermodynamic data was obtained 
for sequences of nona-lysine and nona-arginine with supported lipids bilayers containing 
varying mole percentages of PG and ortho-rhodamine B.  This approach is unique in its 
simplicity and ability to provide sequentially built binding isotherms of small basic 
peptides to supported lipid bilayers and the results confirm the increased affinity of 
arginine over lysine in PG association as well as increased affinity for bilayers 
containing a higher mole percentage of PG. Interestingly, the binding isotherms suggest 
that lysine peptides experience a non-cooperative effect upon binding, which may be 
attributed to the buildup of positive charge on the bilayer thereby resulting in repulsive 
electrostatic forces. Arginine, however, shows this non-cooperative effect only at low 
PG concentrations, suggesting that long-range repulsive effects become outweighed by  
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Figure 4.1. Schematic for Peptide Sensing Assay. A supported lipid bilayer containing 
pH sensitive dye and negative phospholipids (POPG in green) is exposed to positively 
charged peptide, thereby recruiting hydroxide ions to the membrane surface and 
deprotonating the fluorescent reporter. 
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short-range attraction at higher PG concentrations due to the ability of the guanidinium 
moieties to interact with one another.
106
  
 
Flow-Cell and pH Titration Curves. Initially, bilayers containing differing 
mole percentages of 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
(sodium salt) (POPG) were prepared utilizing PDMS micro-contact techniques.
58,107
 
Vesicles containing the appropriate concentration of POPG were incubated in a PDMS 
well on glass that had previously been stamped with bovine fibrinogen using a PDMS 
stamp. After a ten minute incubation, the excess vesicles were rinsed away and the flow 
cell was assembled, allowing for solution to flow over the bilayer formed on the bare 
glass surface (Figure 4.2). Solutions of 10 mM PBS solution containing 150 mM NaCl 
were adjusted to specific pH values and flowed into the flow cell. Fluorescence images 
were taken until the intensity stabilized, and these values were used to form titration 
curves as seen in Figure 4.3. Data points were normalized to the highest intensity and fit 
with a sigmoidal curve, from which apparent pKa values were extracted. As can be 
expected, the apparent pKa of the ortho-rhodamine B dye shifts to higher values as the 
percentage of PG in the bilayer is increased (Table 4.1). This would indicate that with an 
increasingly negative membrane the bulk pH must be adjusted to higher values to 
effectively deprotonate the dye at the bilayer surface. There lies within these titration  
curves a linear range that spans approximately one pH unit and it is within this range that 
binding measurements are performed.  
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Figure 4.2. Fluorescence Micrograph and Line Scans for Bilayers in Flow Cell. On the 
left a fluorescence micrograph of supported lipid bilayers containing ortho-rhodamine B 
POPE patterned down on bare glass between fibrinogen-passivated regions. Solution 
containing different peptide concentrations were flowed over the bilayers, and 
fluorescence intensity measurements were made accordingly. The line scan on the right 
shows the fluorescence intensity corresponding to that region marked by the dashed red 
line in the micrograph. 
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Figure 4.3. pH Titration Curves for Different mol% POPG Bilayers. Titration curves for 
5, 10, 20, and 30 mol% POPG bilayers with 0.5 mol% ortho-rhodamine B POPE and the 
remainder POPC. All titration curves were taken with 10 mM PBS with 150 mM NaCl. 
Apparent pKa values are 6.3, 6.6, 6.9, and 7.3 for 5, 10, 20, and 30 mol% POPG 
bilayers, respectively. 
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Table 4.1. Summary of Peptide Binding Data for Different PG Concentrations. 
 
mol% 
POPG 
            K9            R9 app. pKa 
10 mM PBS 
150 mM NaCl 
KD(µM) n KD(nM) n 
5 77 ± 20* 0.12* 460 ± 47 0.68 6.3 
10 55 ± 3 0.22 124 ± 16 0.73 6.6 
20 2.5 ± 0.5 0.24 38.5 ± 5 1.0 6.9 
30 2.1 ± 0.8 0.19 29.3 ± 7 1.0 7.1 
*assay performed at pH 6.4; all others performed at pH 6.8 
 
Nona Lysine Binding Experiments. To monitor the interaction of nona-lysine 
with the supported lipid bilayer, 10 mM PBS buffer with 150 mM NaCl at a pH of 6.8 
was flowed through the flow cell until stabilization of fluorescence intensity occurred. 
This stabilized fluorescence was recorded with micrographs at five minute intervals, and 
upon achieving stabilization, the lowest concentration of peptide was suspended in the 
same buffer and flowed over the bilayer. Micrographs were taken every five minutes 
until the fluorescence intensity again stabilized, at which time a higher concentration of 
peptide was introduced. Line scans across the bilayer regions were taken to determine 
the fluorescence intensity measurements, as shown in Figure 4.2. A graph of the 
fluorescence intensity values recorded with respect to time, normalized to an initial 
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intensity of 1, can be seen in Figure 4.4. It is possible to fit a binding isotherm by 
plotting the negative of the change in fluorescence normalized to the maximum change 
in fluorescence for the highest peptide concentration added. Interestingly, this plot is not 
well fit with a single Langmuir isotherm. Instead, it seems to be best fit with a Hill-
Waud (eq 4.1) binding model, which is indicative of some form of cooperativity in the 
binding process. By fitting the data to this isotherm, it is possible to extract equilibrium 
binding constants:   
  (4.1) 
   
where F is the fluorescence intensity value due to the binding of peptide to the bilayer 
surface (in this case the negative of the change in fluorescence intensity with respect to a 
starting intensity of 1), Fmax is the maximum change in the fluorescence intensity at a 
peptide concentration that would theoretically saturate the bilayer surface, [P] is the bulk 
peptide concentration, KD  is the apparent dissociation constant and n is the Hill 
coefficient of cooperativity. The binding isotherms for nona-lysine interacting with 
bilayers containing 10, 20, and 30 mol% POPG can be seen in Figure 4.5. These binding 
isotherms were all conducted at pH 6.8 in 10 mM PBS with 150 mM NaCl. Apparent 
dissociation constants extracted from these isotherms have values of 55 ± 3, 2.5 ± 0.5, 
and 2.1 ± 0.8 µM for 10, 20, and 30 mol% PG bilayers, respectively. The Hill-Waud fit 
for these data sets gives n values that are well below unity, indicating this process 
experiences negative cooperativity. This may be attributed to the buildup of positively 
charged peptide at the bilayer surface, which over time may lead to a reversal of the zeta  
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Figure 4.4. Fluorescent Intensity vs. Time for Nona-Lysine Assay. Normalized 
fluorescence intensity measurements for bilayers composed of 0.5 mol% ortho-
rhodamine B POPE, 30 mol% POPG and 69.5 mol% POPC as increasing concentrations 
of nona-lysine (K9) peptide is introduced. The buffer used was 10 mM PBS with 150 
mM NaCl at pH 6.8. 
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Figure 4.5. Nona Lysine Binding Isotherms for 10, 20, and 30 mol% POPG. Hill-Waud 
binding isotherms for nona-lysine (K9) associating with a) 10, b) 20 and c) 30 mol% 
POPG bilayers in 10 mM PBS with 150 mM NaCl at pH 6.8. 
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potential of the membrane surface. Indeed, it has been reported that vesicles with anionic 
lipids can experience a reversal of charge upon incubation with high concentration of 
cationic peptides.
4,12
 Unpublished electrophoresis data performed in our laboratory have 
indicated that this may indeed be the case, as more and more positive peptide 
accumulates on the bilayer. It is known that poly-lysine will not penetrate beyond the 
membrane head group region,
104,108,109
 suggesting that the electrostatically-driven 
binding process could experience negative cooperativity as positive charge builds up on 
the bilayer surface.  
 It is important to note that this assay may not differentiate between the localized 
hydroxide activity that is modulated due to a charged peptide binding event and the 
modulation of bulk solution pH due to high concentration of titratable species, such as 
nona-lysine. To verify that the fluorescence signal is indeed due to localized binding 
events, control experiments were run with bilayers containing 0.5 mol% ortho-
rhodamine B POPE and POPC with high concentrations of nona-lysine. In this case, no 
peptide should associate with the bilayer surface and any modulation in fluorescence 
intensity should be due to bulk pH fluctuation. As can be seen in Figure 4.6, even at the 
highest concentration of nona-lysine utilized in these experiments, there is little 
discernible change in the fluorescence intensity, suggesting that measured signal is 
indeed due to direct association of the peptide with the bilayer surface.   
 An additional nona-lysine experiment was performed on bilayers composed of 
0.5 mol% ortho-rhodamine B POPE, 5 mol% POPG and POPC. In this case, the assay 
was run at a pH of 6.4 as opposed to 6.8. The binding isotherm again shows a best fit to  
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Figure 4.6. Control Assay with POPC Bilayer. Control experiment showing 
fluorescence intensity measurements for a bilayer composed of 0.5 mol% ortho-
rhodamine B POPE and POPC. The colored points indicate times at which increasing 
concentrations of nona-lysine were added, revealing that the bulk pH is not being 
modulated by the addition of peptide. 
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the Hill-Waud model with negative cooperativity with an apparent KD value of 77 ± 20 
µM (Figure 4.7). As the pH is lowered, one would expect the possibility of having a 
more positively charged peptide in the case of nona-lysine. It is known that decreasing 
the ionic strength results in stronger binding for these systems,
4
 suggesting that 
modulating the charged state of the peptide could increase the binding affinity to anionic 
bilayers. This should be taken into account when viewing the Hill coefficients for these 
four bilayer systems (Table 4.1), as a 5 mol% PG bilayer would seemingly give rise to 
less negative cooperativity due to a decreased binding density on the bilayer surface. 
 
Nona Arginine Binding Experiments. Experiments were then performed 
wherein varying concentrations of nona-arginine peptide were flowed over supported 
lipid bilayers of varying POPG concentrations in a flow cell device. In a similar manner, 
decreased fluorescence of the bilayer was observed for increasing concentrations of 
nona-arginine and plotting the negative of the change in fluorescence relative to the 
change in fluorescence of the highest concentration of peptide added allows for the 
formulation of binding isotherms (Figure 4.8).  These assays were performed in 10 mM 
PBS with 150 mM NaCl at a pH of 6.8. Comparison of the apparent Kd values for the 
nona-arginine with the nona-lysine confirms the higher affinity of these poly-arginine 
peptides for anionic phospholipid bilayers (Table 4.1). As for the nona-lysine peptide, 
both 5 and 10 mol% POPG bilayers give fluorescence response signals that are best fit to 
a Hill-Waud isotherm showing negative cooperativity with Hill values less than unity. 
As can be seen in Table 4.1, the Hill coefficient values are much closer to unity than  
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Figure 4.7. Nona Lysine Binding Isotherm for 5 mol% POPG. Hill-Waud fit to 
fluorescence intensity measurements for bilayers composed of 0.5 mol% ortho-
rhodamine B POPE, 5 mol% POPG, 94.5 mol% POPC with the addition of nona-lysine 
(K9) in 10 mM PBS with 150 mM NaCl at pH 6.4.  
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Figure 4.8. Nona Arginine Binding Isotherms. Binding isotherms for nona-arginine 
peptide associating with a) 5, b) 10, c) 20 and d) 30 mol% POPG. All measurements 
were made in 10 mM PBS with 150 mM NaCl at pH 6.8. 
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those values calculated for nona-lysine binding. In addition, the bilayers composed of 20 
and 30 mol% POPG are best fit with Hill coefficients of one, suggesting  non- 
cooperativity in which a traditional Langmuir isotherm accurately describes the fitting. 
 
Discussion. The structural make up of nona-lysine and nona-arginine peptides is 
similar in many ways. Both of these peptides are highly positively charged and are well 
known to associate with anionic phospholipids, especially phosphatidylglycerol and 
phosphatidylserine.
4
 However, polypeptides of these two amino acids show very 
different behavior, both in the strength and mode of their interaction. It has been shown 
that lysine, although associated with cell-penetrating peptide sequences such as the TAT 
domain of HIV, does not show propensity to translocate membranes to become 
internalized as a homogenous polypeptide.
110
 Arginine has been shown to not only 
improve the membrane-penetrating capacity of polypeptide sequences such as the TAT 
domain of HIV when it is substituted in place of the inherent lysine residues,
111
 but 
exhibits membrane-translocating behavior as a homogeneous polypeptide as well.
112
 The 
difference in behavior between these two amino acids must lie in the nature of their 
cationic moieties. 
 Lysine, with an ammonium group comprising its charged moiety, can be 
expected to interact predominately via electrostatic effects. The technique presented here 
affords the ability to monitor the interaction of nona-lysine peptides with supported lipid 
bilayers containing various concentrations of PG in a label-free manner while extracting 
thermodynamic spectroscopic data. It is interesting that the binding isotherms do not 
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show single Kd Langmuir isotherm binding behavior but instead are well fit by Hill-
Waud isotherms. Indeed, the thermodynamic data herein suggests that these peptides 
experience negative cooperativity in their binding to PG-containing bilayers as is 
suggested by Hill coefficients significantly below unity. This negative cooperativity may 
be attributed to the gradual reversal of the potential of the membrane surface as lysine 
peptide begins to populate the head group region. In a monovalent salt solution such as 
is the case here, the surface potential (ψ0)can be related to the surface charge density (σ0) 
by the Graeme equation: 
 
 
where ϵ0 is the permittivity of a vacuum, ϵ is the relative permittivity of water, k is the 
Boltzmann constant, e is the magnitude of electronic charge and T is the temperature. 
When |ψ(0)| is < 25 mV, this can be reduced to 
 
 
   
showing that the surface potential is proportional to the surface charge density under 
these conditions. As nona-lysine residues begin to populate the surface, each peptide is 
predicted to bind up to eight PG lipids,
4
 with the result being a reversal of surface charge 
density and therefore surface potential. The reversal of charge on PG vesicles has been 
shown with penta-lysine
4
 and electrophoretic results in our laboratory have also 
suggested that the membrane potential can be reversed upon peptide binding. In light of 
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this,  negative cooperativity seems justified and should be exacerbated upon higher PG 
concentrations. 
 For the binding of poly-arginine peptides, the situation is slightly more 
complicated, and can be attributed to the guanidinium present as the cationic moiety. In 
addition to purely electrostatic interactions, arginine is believed to experience some non-
electrostatic interaction mechanisms such as hydrogen bonding, which has been 
attributed to interactions of arginine with phospholipids.
113
  Although arginine residues 
are highly charged, there is evidence that they may overcome typical like-charge 
repulsion with the capacity for pairing such as is found in some protein structures.
114,115
 
Guanidinium ions have been shown to form parallel stacks in solution,
116
 and 
computational work done with molecular dynamics and ab initio calculations has 
confirmed the ability of guanidinium pairing in arginine-rich peptides as well as in 
solution.
106
 The ability for the guanidinium moiety in poly-arginine peptides to 
experience close-range attraction due to its capacity to form parallel stacks helps to 
explain the trend that is observed in the binding isotherms for nona-arginine peptides in 
this study. Hill-Waud fits to the thermodynamic data show a trend in the Hill coefficient 
wherein the binding of nona-arginine experiences less negative cooperativity as the 
concentration of PG in the bilayer increases, with the higher concentrations showing a 
best fit with a Hill coefficient of one.  
Guanidinium, being a planar ion, has the ability to form in-plane hydrogen bonds 
upon binding to anionic membranes. Likewise, these peptides show tighter binding 
behavior than the purely electrostatic poly lysine, as can be seen from the apparent Kd 
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values. The parallel stacking that can lead to like-charge association between 
guanidinium ions occurs on the weakly hydrated face of the ion. With increased 
concentration of PG in the bilayer, one would expect this close range interaction to begin 
to dominate the long-range electrostatic repulsion between guanidinium moieties on poly 
arginine peptides, as is manifested in the Hill coefficient trend for this system.  
The studies herein may be extended to observing the interaction of these peptide 
sequences with different anionic phospholipids, such as phosphatidylserine, and the 
effect of such additives as cholesterol. In addition to offering some thermodynamic 
insight into the differences in binding modes of poly lysine and arginine peptides, this 
simple label-free assay by be extended in its general use as a potential screen for basic 
peptide sequences associating with anionic membranes in general. With the utilization of 
multiplexed microfluidic devices, apparent dissociation constants for multiple peptide 
sequences may be determined simultaneously, while avoiding the cost and perturbation 
of fluorescent labels.  
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CHAPTER V 
LABEL-FREE MONITORING OF PROTEIN-PHOSPHATIDYLSERINE 
INTERACTIONS ON SUPPORTED LIPID BILAYERS 
 
Introduction.  Phosphatidylserine (PS) constitutes the most prevalent negatively 
charged phospholipid species in eukaryotic cells and as such is involved with many 
important signaling processes as well as recruitment and activation of enzymes. PS is the 
key phospholipid signaler that is recognized by macrophages in the process of clearing 
apoptotic cells.
117
 Distribution of PS in cell membrane leaflets is highly asymmetrical, 
with the majority being located in the inner leaflet and thus maintained by the action of 
flippase enzymes and it is believed that inhibition of this enzyme coupled with the 
activity of scramblase enzymes contribute to reversal of PS distribution,
118
 along with 
lysosome fusion-mediated redistribution.
119
 The presentation of PS on the extracellular 
membrane is vital in such processes as the coagulation cascade in hemostasis 
processes.
120
 Coagulation proteins such as coagulation factor V and prothrombin 
recognize the PS headgroup  specifically, though with different structural features in 
their binding domains.
121,122
 The function of intracellular PS is also associated with 
protein binding and function as well, serving as the target for species such as protein 
kinase C (PKC), which is activated upon binding.  
 Among the various protein domains associated with PS-binding there exists a 
range of specificity from general anionic-phospholipid binding regions rich in cationic 
residues to more PS-specific C2 domains. The mode of traditional PKC binding to PS 
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involves such a domain. The C2 region recognizes and binds PS via a calcium-
dependent interaction, whereby the protein undergoes structural alteration and is 
consequently activated.
47
 Traditional PKC, which includes isoforms α, βI, βII, and γ, is 
regulated by diacylglycerol in addition to this calcium-mediated interaction with PS. It is 
the C2 domain, containing specific Ca
2+
 binding regions, which is key in maintaining the 
enzyme in a bound state with phospholipid membranes.
123,124
 The C2 domain is also of 
considerable interest due to its structural feature, which contains two loops by which 
calcium is coordinated and PS binding facilitated. These loops have been shown to have 
bound Ca
2+
 displaced by Pb
2+
 in the presence of PS lipid membranes, suggesting one 
potential molecular manifestation of well-known but little-understood Pb toxicity.
48
 
 Recently, we have discovered that PS can bind Cu
2+
 with extremely high affinity 
in  a 2:1 PS:Cu
2+
 complex, a phenomena that is accompanied in bilayers by the 
quenching of nearby fluorescently labeled phospholipids.
49
 This process is reversible and 
de-quenching can be facilitated by lowering the pH of the solution causing the 
consequential protonation of the PS molecules. The concentration of Cu
2+
 that is 
necessary for this quenching to occur is also impressively low, with the equilibrium 
dissociation constant being in the femtomolar range. In fact, the extremely high affinity 
of this interaction and its obvious fluorescent response has brought to light the 
ubiquitous nature of trace Cu
2+
 contamination in buffers, water sources, and various 
laboratory products such as polytetrafluoroethylene tubing. Without the implementation 
of PS and fluorescently-tagged phospholipid bilayers, the presence of these Cu
2+
 ions 
might not have been recognized. This observation presents the possibility that numerous 
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PS studies, especially those performed in membranes, may be performed in the presence 
of this strongly associating complex. Herein we describe the utilization of this PS-Cu
2+
 
induced quenching as a mode for detecting the C2 PS-binding domain of protein kinase 
Cα (C2α). This strategy involves the formulation of supported lipid bilayers in 
microfluidic channels composed of 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium 
salt) (DOPS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 
fluorescently labeled 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphoethanolamine) (POPE).  Initially, buffer containing µM concentrations of CaCl2 
and nM concentrations of CuCl2 is flown over the bilayers, resulting in the PS-Cu
2+
 
quenching of phospholipid-linked fluorophores, in this case the pH-insensitive para 
isomer of rhodamine B. This quenched state is then disrupted by then introducing 
varying concentrations of C2α, which disrupts the Cu2+ ion-induced quenching and 
results in a turn-on fluorescent response (Figure 5.1). It is possible to elucidate binding 
isotherms from this fluorescent data, which yield dissociation constants that agree very 
well with published values for this system. 
 
C2α Binding Experiments.  Initially, vesicles composed of 0.5 mol% para-
rhodamine B, 20 mol% DOPS and 79.5 mol% POPC were created. Para-rhodamine B, 
unlike the ortho isomer, is pH insensitive and therefore should not fluctuate intensity due 
to any perturbation of the hydroxide activity a charged protein may induce at the 
membrane surface upon binding. Instead, the fluorescent signal should come directly  
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Figure 5.1.  Schematic of PS-Cu
2+
 Sensing Assay. Initially a bilayer containing POPC, 
DOPS, and para-rhodamine B POPE (pRB) is in equilibrium with Cu
2+
 in solution with 
much of the fluorophore in a quenched state (a). Upon the addition of Ca
2+
 complexed 
C2α, the PS-Cu2+ complex is disrupted, consequently de-quenching the dye and 
increasing the fluorescence intensity of the bilayer (b). 
 
 
 
 
 
 
 
 65 
from the disruption of the 2 PS-Cu
2+
-induced quenched state that has initially been 
established. After introducing vesicles into the microfluidic channels and allowing them 
to incubate for 30 minutes, 10 mM MES buffer with 100 mM KCl, 100 µM CaCl2, and 1 
nM CuCl2 at pH 6.1 was flown through the device. Fluorescence micrographs were 
taken at regular intervals until fluorescence stabilization occurred. Line scans were taken 
across the microfluidic channels and measurements were made by averaging the 
intensity of the middle third of each channel, corresponding to the bilayer most 
uninfluenced by channel edge effects. As can be seen in Figure 5.2, the intensity begins 
dropping drastically as the Cu
2+
-induced quenching occurs. For this copper 
concentration at this pH and flow rate, this process takes approximately one hour to 
equilibrate, resulting in a fluorescence intensity that is about 20% of the initial 
unquenched state. This low rate of quenching is indicative of the necessity to form the 
two-lipid complex with the ion, which depends upon the diffusion of PS in the bilayer.
49
 
This process can be reversed by either modulating the pH of the solution to much lower 
values to achieve protonation of the PS or by adding some chelating agent, such as 
ethelenediaminetetraacetic acid (EDTA) or mM concentrations of glycine. This 
quenching phenomena can also be disrupted by the addition of the peripheral membrane 
binding C2 domain of protein kinase Cα (C2α). As can be seen in Figure 5.2, the 
addition of 50 nM C2α results in a de-quenching process as the 2 PS-Cu2+ complex is 
disrupted by the formation of the Ca
2+
-mediated C2α-PS complex. This process takes 
several hours to equilibrate and indeed is dependent upon the concentration of Cu
2+
 in 
solution. At higher copper concentrations, in the 100’s of nM, the de-quenching of the  
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Figure 5.2. Fluorescence Intensity Data for Cu
2+
 Quenching and De-quenching. 
Fluorescence intensity measurements for a bilayer in a microfluidic channel consisting 
of 0.5 mol% para-rhodamine B, 20 mol% DOPS, and 79.5 mol% POPC. 10 mM MES 
buffer containing 100 mM KCl, 100 µM CaCl2 and 1 nM CuCl2 was flown into the 
channel until fluorescence intensity stabilized, at which point 50 nM C2α was added in 
the same buffer. 
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fluorophore does not occur with the addition of C2α unless higher concentrations of the 
protein are added, indicating of a direct competition for PS-binding.  
This process was repeated across multiple channels in microfluidic devices to 
establish a binding curve for C2α in the presence of 100 µM CaCl2. Figure 5.3 shows the 
line scans for four microfluidic channels in which the bilayers have been first 
equilibrated with 1 nM Cu
2+
 in a quenched fluorescence state, and then in an equilibrated 
state after the addition of 500, 100, 10, and 0.5 nM C2α. Figure 5.4 shows the 
fluorescence intensity data for multiple channels as a function of time with the addition 
of various concentrations of C2α. One can see that the rate of de-quenching is somewhat  
varied between concentrations, which can be attributed to the difference in flow rate 
between different microfluidic channels. This data can be fit with a simple Langmuir 
isotherm: 
 
 
 
where F is the change in fluorescence intensity due to C2α-induced de-quenching 
normalized to a maximum change in fluorescence Fmax, C is the concentration of C2α in 
bulk solution and Kd is the apparent dissociation constant. This isotherm fitting (Figure 
5.5) gives an apparent Kd value of 75 ± 8 nM, which agrees well with previously 
reported values determined by surface plasmon resonance.
48,125
 It is important to note 
that in the absence of any intentional CaCl2, the addition of C2α also showed some de-  
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Figure 5.3. Line Scans for C2α Sensing Assay. Line scans for microfluidic channels 
containing bilayers composed of 0.5 mol% para-rhodamine B, 20 mol% DOPS and 79.5 
mol% POPC. Fluorescence intensity was equilibrated in 10 mM MES buffer with 100 
mM KCl, 100 µM CaCl2, and 1 nM CuCl2 (black line). Fluorescence intensity increased 
and stabilized (red line) after the addition of a) 500 b) 100 c) 10, and d) 0.5 nM C2α. 
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Figure 5.4. Fluorescence Intensity Data for C2α Sensing Assay. Fluorescent intensity 
measurements versus time for microfluidic channels containing bilayers composed of 0.5 
mol% para-rhodamine B, 20 mol% DOPS and 79.5 mol% POPC. Differing 
concentrations of C2α were flown in a buffer consisting of 10 mM MES with 100 mM 
KCl, 100 µM CaCl2 and 1 nM CuCl2. 
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Figure 5.5. Binding Isotherm for C2α. Langmuir isotherm fit to the fluorescence 
intensity change upon addition of C2α to bilayers composed of 0.5 mol% para-
rhodamine B POPE, 20 mol% DOPS, and 79 mol% POPC in10 mM MES with 100 mM 
KCl, 100 µM CaCl2 and 1 nM CuCl2.  
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quenching of the bilayer fluorescence, though to a lesser extent that in the presence of 
calcium. NMR data can reveal if Cu
2+
 can be bound by C2α in  a similar manner to Ca2+, 
which would explain the dequenching observed upon addition of C2α in the absence of 
calcium. These studies are ongoing. 
 
Discussion. The data presented herein leads to some interesting implications. 
Firstly, as PS concentrations in vivo are estimated to be in the micromolar to low 
millimolar
43
 range and involved in numerous signaling cascades, and considering the 
high affinity
49
 that PS has shown to bind Cu
2+
, it is possible that competition for PS 
binding may be occurring with such proteins as PKC. This work has demonstrated that 
the disruption of the two-serine mediated Cu
2+
 bound complex is possible via the 
introduction of the PS-binding C2 domain of  PKC with no apparent affect on the 
observed dissociation constants for this species in the presence of calcium. This is an 
interesting disruption to occur, as it involves two different ions which interact differently 
with PS. Whereas the calcium ion is bound in conjuncture with the phosphate group, the 
copper ion is held between two serine residues of neighboring PS molecules. It was 
shown that Ca
2+
 alone can to some extent displace Cu
2+
 and lead to de-quenching, 
though it must be present in great excess.
49
 However, in the case of C2α, there was 
evidence of de-quenching at concentrations comparable to bulk Cu
2+
.  
The high affinity that Cu
2+
 has for PS may be evidence that this phospholipid 
plays some role in sequestering any free Cu
2+
 that may be present in the cell. If PS is 
indeed involved in sequestering free Cu
2+
 and neutralizing these toxic species,
126,127
 it 
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may be that this function does not significantly disrupt the role this phospholipid plays 
as an activator in signaling pathways for cell proliferation and differentiation, such as 
those is mediated by PKC.
128
 Although at high Cu
2+
 concentrations (above 50 nM) there 
seems to be no de-quenching effect upon addition of C2α, indicating that at this 
concentration there is no significant C2α binding to PS, in a cell free copper ion 
concentration is believed to be extremely low,
129
 with the majority that is present for 
enzymatic function in Cu
+
 form.
126
   
Another implication is in the technique itself. It would follow that this strategy 
may be useful to observe in a label-free manner many classes of PS-binding proteins 
such as annexin V or prothrombin. In addition to the large signal that is generated and its 
relative simplicity, this assay strategy affords the ability to discover the effect that Cu
2+
 
may have on the PS-binding behavior of these proteins, gaining insight into this bio-
metallic system.  
It is worth noting that in addition to the strategy presented here, binding of C2α 
to PS was also observed utilizing a pH-sensitive fluorophore, though the signal to noise 
was not as high as for the Cu
2+
 de-quenching assay. 
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CHAPTER VI 
CONCLUSIONS 
 
 Discussion.  The focus of this research has been the exploration and development 
of label-free fluorescence-based sensors utilizing supported lipid bilayers. The 
advantages of this strategy include its simplicity of implementation, its adaptation to 
biologically relevant studies, the fact that it is easily amenable to multiplexing in 
microfluidic devices, and perhaps most importantly the ability to monitor analytes in a 
label-free manner. Herein, with the use of supported lipid bilayers, this technique is 
operated in a heterogeneous manner. However, it is possible and has been shown that 
this strategy is amenable to homogeneous systems as well.
130
 In this manifestation, 
wherein a protein is fluorescently labeled with a pH-sensitive dye, the interaction with 
its binding partner can be monitored and binding isotherms can be extracted. This 
strategy has shown to be able to detect protein-protein, protein-small molecule, and 
protein-ion interactions in bulk solution. Considering the simplicity of operation and the 
variety of interactions it is capable of accurately monitoring, this technique seems to be a 
choice strategy for use in initial screening assays, where a wide variety of targets, such 
as drugs or peptides, can be run simultaneously allowing for the most promising 
candidates to be isolated for more in-depth analysis and study. 
 As with any technique, the label-free sensing strategies presented herein have 
their inherent limitations. Assays utilizing the pH-modulation approach must involve the 
detection of a charged species, and the operating pH range should be confined to that 
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region of linear response from the reporter fluorophore. This is a facet that must be taken 
into consideration when considering this strategy, although it has been shown that these 
ranges can be modulated by altering buffer conditions, reporter dyes, or bilayer 
chemistries. For the utilization of the PS-Cu
2+
 sensing approach the obvious limitation is 
inherent to the inclusion of these two species. Ultimately, as with any technique, one 
must identify those candidates which are most amenable to the advantages that a 
particular strategy affords. The opportunity to collaborate with both the Pellois 
laboratory for the peptide studies presented and the Igumenova laboratory for the C2α 
investigations has proven to be helpful in discovering specific applications for these 
sensing strategies that have interesting biological implications. The future of this work 
lies in the ability to find new and interesting systems whereby simple and rapid label-
free monitoring, especially on supported lipid bilayers, can offer insight. 
 
A Few Comments on Microfluidics. Throughout the course of this research, 
microfluidic devices have been utilized extensively. It is safe to assume that over a 
thousand individual devices have been produced and utilized, and some interesting 
observations warrant mentioning here. Firstly, it has been noticed that, in the case of pH-
sensitive fluorophore-doped bilayers in microfluidic channels, the continuous flowing of 
buffer becomes important for maintaining the pH within the channel, especially as one 
drifts further from the buffering region of a particular buffering species. It was noticed 
that when fluid flow was stopped, the fluorescence intensity of pH-sensitive 
fluorophores in bilayers would begin to drift in a manner that suggested a gradual 
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lowering of solution pH. As can be seen in Figure 6.1, bilayers containing fluorescein 
dye, which fluoresces at high pH but is less fluorescent at lower pH, can be seen to drop 
in fluorescence intensity as flow through the microfluidic channel is stopped. When flow 
is resumed, the intensity quickly rises to the initial value, until flow is again stopped and 
the intensity begins to fall. This can also be observed in Figure 6.2, where the 
fluorescence intensity of bilayers containing ortho-Texas Red DHPE, which fluoresces it 
lower pH values but loses its fluorescence as it is deprotonated, is observed to increase 
with time in static microfluidic channels. These bilayers are being buffered by 10 mM 
PBS and as can be seen, the further one is from the buffering range of this species, the 
more intense the change in fluorescence observed upon stopping the flow. The behavior 
of these two fluorescent species suggests that with stopped flow, a volume such as is 
contained within a microfluidic channel (less than 1 µL in this case) is extremely 
susceptible to pH drift, most likely from CO2 navigating through the semi-porous 
PDMS, though this is yet to be confirmed.  
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Figure 6.1. Fluorescence Intensity Data with Start and Stop Flow. Fluorescence 
intensity measurements for fluorescein-labeled phospholipid in a supported lipid bilayer 
within a microfluidic channel. Green and red circles represent time at which the flow of 
buffer (10 mM PBS with 150 mM NaCl at pH 9.7) was started and stopped, respectively. 
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Figure 6.2. Fluorescence Intensity Data with Stopped Flow at Different pH’s. 
Fluorescence intensity measurements for ortho-rhodamine B POPE-containing bilayers 
in  microfluidic channels after flow of 10 mM PBS buffer with 150 mM NaCl at various 
pH values had been stopped. 
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 Additionally, it is interesting to note that the small dimensions of a microfluidic 
channel have an effect on the apparent pKa values of pH-responsive dyes, as can be seen 
from Figure 6.3. In a microfluidic device, a bilayer consisting of 0.5 mol% ortho-
rhodamine B POPE, 30 mol% POPG and 69.5 mol% POPC the apparent pKa of the 
fluorophore in 10 mM PBS with 150 mM NaCl is about 7.3, whereas the same system in 
a flow cell has a slightly lower pKa value of 7.1. While this shift may not seem 
significant, it speaks to the highly confined nature of a microfluidic channel, where it is 
apparent that the deprotonation of the fluorophore requires a slightly more basic bulk 
solution. Such subtleties in the differences between bilayers in microfluidics and 
otherwise require a more thorough investigation than the few observations presented 
here, and may lead to some interesting and useful biophysical observations.  
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Figure 6.3. Comparison of pH Titration in Microfluidic and Flow Cell. Comparison of 
pH titration curves for bilayers composed of 0.5 mol% ortho-rhodamine B POPE, 30 
mol% POPG, and 69.5 mol% POPC in both a microfluidic device and a flow cell. 10 
mM PBS with 150 mM NaCl was used in both titrations. 
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